Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/8/06 → 8/10/10 |
Funding
- Coley Pharmaceutical Group, Inc. (CPG 10101-004)
Prot# CPG 10101-004: CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase II Randomized, Open-Label, Multi-Center, Parallel Arm, Controlled Trial of CPG 10101 at 2 Different Dose Levels w/Pegylated-Interferon-Alpha 2B (PEG-IFN) Plus Rib
- Flamm, Steven L (PD/PI)
Project: Research project